10-43100731-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020975.6(RET):​c.337+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.25 in 1,583,280 control chromosomes in the GnomAD database, including 52,243 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3868 hom., cov: 31)
Exomes 𝑓: 0.25 ( 48375 hom. )

Consequence

RET
NM_020975.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 1.12
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-43100731-G-A is Benign according to our data. Variant chr10-43100731-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 95996.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-43100731-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RETNM_020975.6 linkuse as main transcriptc.337+9G>A intron_variant ENST00000355710.8 NP_066124.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RETENST00000355710.8 linkuse as main transcriptc.337+9G>A intron_variant 5 NM_020975.6 ENSP00000347942 P4P07949-1

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31729
AN:
151540
Hom.:
3864
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0949
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.260
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.291
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.261
Gnomad NFE
AF:
0.259
Gnomad OTH
AF:
0.212
GnomAD3 exomes
AF:
0.257
AC:
50491
AN:
196552
Hom.:
7063
AF XY:
0.258
AC XY:
27353
AN XY:
106116
show subpopulations
Gnomad AFR exome
AF:
0.0954
Gnomad AMR exome
AF:
0.356
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.102
Gnomad SAS exome
AF:
0.303
Gnomad FIN exome
AF:
0.258
Gnomad NFE exome
AF:
0.259
Gnomad OTH exome
AF:
0.267
GnomAD4 exome
AF:
0.255
AC:
364788
AN:
1431622
Hom.:
48375
Cov.:
51
AF XY:
0.256
AC XY:
181424
AN XY:
709260
show subpopulations
Gnomad4 AFR exome
AF:
0.0896
Gnomad4 AMR exome
AF:
0.342
Gnomad4 ASJ exome
AF:
0.246
Gnomad4 EAS exome
AF:
0.0886
Gnomad4 SAS exome
AF:
0.302
Gnomad4 FIN exome
AF:
0.255
Gnomad4 NFE exome
AF:
0.260
Gnomad4 OTH exome
AF:
0.241
GnomAD4 genome
AF:
0.209
AC:
31738
AN:
151658
Hom.:
3868
Cov.:
31
AF XY:
0.212
AC XY:
15735
AN XY:
74094
show subpopulations
Gnomad4 AFR
AF:
0.0947
Gnomad4 AMR
AF:
0.260
Gnomad4 ASJ
AF:
0.246
Gnomad4 EAS
AF:
0.101
Gnomad4 SAS
AF:
0.292
Gnomad4 FIN
AF:
0.258
Gnomad4 NFE
AF:
0.259
Gnomad4 OTH
AF:
0.210
Alfa
AF:
0.243
Hom.:
1656
Bravo
AF:
0.207
Asia WGS
AF:
0.182
AC:
631
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 19, 2018This variant is classified as benign because it has been identified in 36% (1044 7/29350) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http: //gnomad.broadinstitute.org; dbSNP rs2435351). ACMG/AMP Criteria applied: BA1. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 31, 2014- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 12872262) -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Multiple endocrine neoplasia type 2B Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Pheochromocytoma Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Hirschsprung disease, susceptibility to, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Renal hypodysplasia/aplasia 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Multiple endocrine neoplasia type 2A Benign:1
Benign, criteria provided, single submitterclinical testingGenetics and Molecular Pathology, SA PathologyAug 06, 2019- -
Multiple endocrine neoplasia, type 2 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Multiple endocrine neoplasia Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 30, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
11
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2435351; hg19: chr10-43596179; COSMIC: COSV60687075; COSMIC: COSV60687075; API